Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pulmonary toxicity of mitomycin

A U Buzdar, S S Legha, M A Luna

    Cancer
    |January 15, 1980
    PubMed
    Summary

    Mitomycin therapy can cause lung toxicity in breast cancer patients, presenting as shortness of breath and cough. Early treatment with corticosteroids and drug discontinuation may reverse these pulmonary effects.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Genomic characterization of HER2-positive breast cancer and response to neoadjuvant trastuzumab and chemotherapy-results from the ACOSOG Z1041 (Alliance) trial.

    Annals of oncology : official journal of the European Society for Medical Oncology·2017
    Same author

    Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511).

    Breast cancer research and treatment·2016
    Same author

    Which threshold for ER positivity? a retrospective study based on 9639 patients.

    Annals of oncology : official journal of the European Society for Medical Oncology·2014
    Same author

    Pathologic complete response to neoadjuvant chemotherapy with trastuzumab predicts for improved survival in women with HER2-overexpressing breast cancer.

    Annals of oncology : official journal of the European Society for Medical Oncology·2013
    Same author

    Randomized phase II non-inferiority study (NO16853) of two different doses of capecitabine in combination with docetaxel for locally advanced/metastatic breast cancer.

    Annals of oncology : official journal of the European Society for Medical Oncology·2011
    Same author

    Role of biologic therapy and chemotherapy in hormone receptor- and HER2-positive breast cancer.

    Annals of oncology : official journal of the European Society for Medical Oncology·2009

    Area of Science:

    • Oncology
    • Pulmonology
    • Pharmacology

    Background:

    • Mitomycin is a chemotherapy agent used in cancer treatment.
    • Pulmonary toxicity is a potential adverse effect of chemotherapy.
    • Identifying and managing drug-induced lung injury is crucial for patient outcomes.

    Purpose of the Study:

    • To investigate the clinical presentation, radiological findings, and histological characteristics of mitomycin-induced pulmonary toxicity.
    • To evaluate the efficacy of treatment strategies, including drug discontinuation and corticosteroid administration.

    Main Methods:

    • Case series of six breast cancer patients experiencing pulmonary symptoms after mitomycin therapy.
    • Review of clinical presentation, chest radiography, and lung biopsy findings.
    • Analysis of treatment responses to drug withdrawal and corticosteroid therapy.

    Main Results:

    • Patients presented with dyspnea and dry cough.
    • Radiological findings ranged from normal to extensive bilateral pneumonitis.
    • Histology showed diffuse alveolar damage progressing to interstitial fibrosis.
    • One patient had complete resolution with corticosteroids; three improved after drug discontinuation.
    • Two untreated patients with severe pneumonitis died from respiratory failure.

    Conclusions:

    • Mitomycin-induced lung toxicity is a significant concern in breast cancer patients.
    • Early recognition, mitomycin discontinuation, and corticosteroid treatment can lead to reversible pulmonary changes.
    • Lung biopsy is essential for differential diagnosis in suspected cases.

    Related Experiment Videos